Skip to content

Comparison of chloroprocaine 1% and bupivacaine 0.5% for spinal anaesthesia in patients undergoing surgeries of duration less than 1 hour

Comparison of intrathecal isobaric chloroprocaine 1% and 0.5% bupivacaine heavy in patients undergoing day care surgeries - A prospective randomised double blind study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013004
Enrollment
60
Registered
2018-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA1/2

Interventions

Intervention1: ISOBARIC CHLOROPROCAINE 1%: Chloroprocaine is a short acting local anaesthetic agent which is reliable and safe to be used in day care surgeries. It is an ester type local anaesthetic a

Sponsors

SDM College Of Medical Sciences and Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients who are undergoing day care surgeries 2.Age:18-65years 3.ASA physical status I and II

Exclusion criteria

Exclusion criteria: 1.Patient refusal 2.Patient of ASAIII and IV 3.Surgeries extending beyond 60minutes 4.Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Post operative two segment regression time of intrathecal isobaric chloroprocaine 1% and 0.5% bupivacaine hyperbaricTimepoint: Start of spinal anaesthesia 1 minute 3 minutes 5 minutes 10 minutes 15 minutes 20 minutes 25 minutes 30 minutes 35 minutes 40 minutes 45 minutes 60 minutes 75 minutes In post anaesthesia care unit : On arrival 15 minutes 30 minutes 45 minutes 60 minutes 75 minutes 90 minutes 120 minutes

Secondary

MeasureTime frame
TO COMPARE HAEMODYNAMIC RESPONSE AND POSTOPERATIVE VOIDING TIME CAUSED BY ADMINISTRATION OF INTRATHECAL CHLOROPROCAINE AND BUPIVACAINETimepoint: 120 MINUTES

Countries

India

Contacts

Public ContactDr Imran Sholapur

SDM College Of Medical Sciences and Hospital

drimransholapur@gmail.com9731047204

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026